Business

Medical Marijuana, Inc. Subsidiary Dixie Botanicals® Announces Launch of Watermelon-Flavored CBD Gummies

Medical Marijuana, Inc. Subsidiary Dixie Botanicals® Announces Launch of Watermelon-Flavored CBD Gummies.

articleMedical Marijuana, Inc.August 7, 20193/company/medical-marijuana-i/news/medical-marijuana-inc-subsidiary-dixie-botanicalsr-announces-launch-of-watermelon-flavored-cbd-gummies
Medical Marijuana, Inc. Subsidiary Dixie Botanicals® Announces Launch of Watermelon-Flavored CBD Gummies

About this update from Medical Marijuana, Inc.

[{"type":"text","content":"\n\n\n\nMedical Marijuana, Inc. Subsidiary Dixie Botanicals® Announces Launch of Watermelon-Flavored CBD Gummies\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nMedical Marijuana, Inc. Subsidiary Dixie Botanicals® Announces Launch of Watermelon-Flavored CBD Gummies\nPR Newswire\nSAN DIEGO, Aug. 7, 2019\n\n\n\nSAN DIEGO, Aug. 7, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Dixie Botanicals® has released new watermelon-flavored cannabidiol (CBD) gummies in response to a growing market demand for edible CBD products.\n\n \n \n\n \nDixie Botanicals® CBD Gummies offer 10 mg of the Company's hemp-derived CBD isolate in each gummy and are tetrahydrocannabinol (THC)-free. These gummies are minimally processed and have undergone a Triple Lab Tested™ process to verify they are free of contaminants and contain reliable levels of CBD. \n\"According to a recent report by the Brightfield Group, the U.S. market for foods and beverages containing hemp-derived CBD could be worth up to $2.5 billion by 2023 – that's 10.5% of the $23.7 billion estimated for the market for all CBD products,\" said Medical Marijuana, Inc. CEO Dr. Stuart Titus. \"As we continue to innovate, we will also continue to stay abreast of these types of market trends and shifting consumer demands. These new gummies allow us to do just that.\"\nCBD gummies have become a highly sought-after CBD product and, according to Google's Annual Search Data Report, they were the third most searched food term in the U.S. on Google in 2018. The U.S. CBD gummy market grew by 925 percent in 2018 alone, presenting a key market opportunity for this new product.\nDixie Botanicals® products are created using CBD oil or isolate extracted from non-GMO hemp plants. \nDixie Botanicals® CBD Gummies come individually wrapped and do not require refrigeration for quic...

More updates from Medical Marijuana, Inc.